India's Glenmark Pharma rises on settling anti-trust lawsuit with plaintiffs

Glenmark Pharmaceuticals

24/02/2025 07:09

** Shares of Glenmark Pharmaceuticals  GLEN.NS  up ~4% to
1350.5 rupees
    ** Co settles remaining antitrust and consumer protection
lawsuits with three plaintiffs in connection with generic
cholesterol drug Zetia
    ** Plaintiffs include Humana  HUM.N , Centene Corp  CNC.N 
and Kaiser Foundation Health Plan  KISERF.UL 
    ** Under terms of $7 mln settlement, Glenmark denies
allegations by plaintiffs, concedes no liability
    ** Including session's gains, GLEN shares up 48.3% in the
last 12 months
    
    
    
    
    

 (Reporting by Ananta Agarwal in Bengaluru)
 ((Ananta.Agarwal@thomsonreuters.com))